<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Volgograd State Medical University</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Volgograd State Medical University</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Волгоградского государственного медицинского университета</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-9480</issn><issn publication-format="electronic">1994-9499</issn><publisher><publisher-name xml:lang="en">Volgograd State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">117787</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Pharmacodynamics of betimil and riboxin in patientswith chronic cardiac failure</article-title><trans-title-group xml:lang="ru"><trans-title>Фармакодинамика бемитила и рибоксинау больных с хронической сердечнойнедостаточностью</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Platonova</surname><given-names>N A</given-names></name><name xml:lang="ru"><surname>Платонова</surname><given-names>А Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра клинической фармакологии и интенсивной терапии; ВолГМУ</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ВолГМУ</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2006-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2006</year></pub-date><volume>3</volume><issue>1</issue><issue-title xml:lang="en">NO1 (2006)</issue-title><issue-title xml:lang="ru">№1 (2006)</issue-title><fpage>50</fpage><lpage>51</lpage><history><date date-type="received" iso-8601-date="2022-12-16"><day>16</day><month>12</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2006, Platonova N.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2006, Платонова А.Н.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder xml:lang="en">Platonova N.A.</copyright-holder><copyright-holder xml:lang="ru">Платонова А.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/1994-9480/article/view/117787">https://journals.eco-vector.com/1994-9480/article/view/117787</self-uri><abstract xml:lang="ru"><p>Evidence-based approach has proved that inclusion of betimil into the treatment of patients with cardiac failure decreases the functional class of the disease more effectively than riboxin.</p></abstract><kwd-group xml:lang="en"><kwd>heart failure</kwd><kwd>coronary disease</kwd><kwd>betimil</kwd><kwd>riboxin</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Мареев В.Ю., Беленков Ю.Н., Агеев Ф.Т. и др. // Сердеч. недостаточность. - 2003. - Т. 4. - № 1. -С.17-18.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Беленков Ю.Н., Мареев В.Ю. Принципы рационального лечения сердечной недостаточности. -М.: Медиа Медика, 2000.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Беленков Ю.Н., Мареев В.Ю., Арутюнов Г.П. и др. // Сердеч. недостаточность. - 2003. - Т. 4. - № 6. -С. 276-297.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Сайфутдинов Р.И., Коц Я., Тихадзе А.К. и др. // Кардиология. - 1990. - № 3. - С. 65-68.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Лукьянова Л.Д. // Итоги науки и техники. Фармакология. Химиотерапевтические средства / Под ред. Л.Д. Лукьяновой. - М., 1991. - С. 5-26.</mixed-citation></ref></ref-list></back></article>
